Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WSC 2026 | The human face of recurrent stroke: beyond physical outcomes

Mike Sharma • 21 Oct 2026
WSC 2026
Stroke
OCEANIC-STROKE

Mike Sharma, MD, MSc, FRCPC, McMaster University, Hamilton, Canada, shares insights into the human face of recurrent stroke. Dr Sharma discusses the importance of considering the psychological burden of stroke on patients, and highlights that patients often experience depression, anxiety, and fear of recurrence, which can significantly impact their quality of life. This interview took place at the 18th World Stroke Congress (WSC) in Seoul, Korea.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Mike Sharma

Incident stroke and time course of benefit of asundexian: analyses of the OCEANIC-STROKE trial
6:08
Incident stroke and time course of benefit of asundexian: analyses of the OCEANIC-STROKE trial
Mike Sharma • 6 May 2026
Which patient characteristics should guide antithrombotic selection after non-cardioembolic stroke?
3:00
Which patient characteristics should guide antithrombotic selection after non-cardioembolic stroke?
Mike Sharma • 9 Apr 2026
Antithrombotic decision-making in stroke, AF, and atherosclerotic disease
1:54
Antithrombotic decision-making in stroke, AF, and atherosclerotic disease
Mike Sharma • 9 Apr 2026
How will factor XIa inhibitors impact the future of secondary stroke prevention?
1:46
How will factor XIa inhibitors impact the future of secondary stroke prevention?
Mike Sharma • 9 Apr 2026

Related Videos

The future of factor XI inhibitors in secondary stroke prevention: asundexian and beyond
3:49
The future of factor XI inhibitors in secondary stroke prevention: asundexian and beyond
S. Claiborne Johnston • 21 Oct 2026
Lessons from TECNO: what next for intra-arterial thrombolysis trials in ischemic stroke?
1:47
Lessons from TECNO: what next for intra-arterial thrombolysis trials in ischemic stroke?
Adnan Mujanovic • 21 Oct 2026
Advances in CVST: endovascular treatment, imaging and antiphospholipid syndrome
1:03
Advances in CVST: endovascular treatment, imaging and antiphospholipid syndrome
Ronen Leker • 21 Oct 2026
Approaches to enhancing reperfusion therapies for AIS: AI, lightweight imaging devices, & more
16:06
Approaches to enhancing reperfusion therapies for AIS: AI, lightweight imaging devices, & more
Geoffrey Donnan et al. • 22 Oct 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals